1. Home
  2. LEGN vs APPF Comparison

LEGN vs APPF Comparison

Compare LEGN & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • APPF
  • Stock Information
  • Founded
  • LEGN 2014
  • APPF 2006
  • Country
  • LEGN United States
  • APPF United States
  • Employees
  • LEGN N/A
  • APPF N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • APPF Computer Software: Prepackaged Software
  • Sector
  • LEGN Health Care
  • APPF Technology
  • Exchange
  • LEGN Nasdaq
  • APPF Nasdaq
  • Market Cap
  • LEGN 7.0B
  • APPF 7.9B
  • IPO Year
  • LEGN 2020
  • APPF 2015
  • Fundamental
  • Price
  • LEGN $27.78
  • APPF $218.91
  • Analyst Decision
  • LEGN Strong Buy
  • APPF Buy
  • Analyst Count
  • LEGN 13
  • APPF 6
  • Target Price
  • LEGN $75.67
  • APPF $271.20
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • APPF 376.8K
  • Earning Date
  • LEGN 05-13-2025
  • APPF 04-24-2025
  • Dividend Yield
  • LEGN N/A
  • APPF N/A
  • EPS Growth
  • LEGN N/A
  • APPF 158.56
  • EPS
  • LEGN N/A
  • APPF 5.36
  • Revenue
  • LEGN $728,303,000.00
  • APPF $824,474,000.00
  • Revenue This Year
  • LEGN $65.96
  • APPF $20.11
  • Revenue Next Year
  • LEGN $52.55
  • APPF $16.68
  • P/E Ratio
  • LEGN N/A
  • APPF $40.97
  • Revenue Growth
  • LEGN 112.46
  • APPF 22.73
  • 52 Week Low
  • LEGN $29.27
  • APPF $189.01
  • 52 Week High
  • LEGN $60.87
  • APPF $274.56
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.61
  • APPF 52.76
  • Support Level
  • LEGN $30.25
  • APPF $209.24
  • Resistance Level
  • LEGN $33.30
  • APPF $222.34
  • Average True Range (ATR)
  • LEGN 1.78
  • APPF 5.74
  • MACD
  • LEGN -0.57
  • APPF 0.76
  • Stochastic Oscillator
  • LEGN 5.19
  • APPF 85.49

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

Share on Social Networks: